SRPT — Sarepta Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Sarepta Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,116	1,989	1,676	1,355	940
Net Total Accounts Receivable
Net Total Receivables	172	260	440	650	520
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,604	2,558	2,579	3,073	2,538
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	237	245	357	489	471
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,148	3,128	3,265	3,963	3,350
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	453	620	654	732	1,095
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,220	2,743	2,405	2,435	2,209
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	928	385	859	1,528	1,141
Total Liabilities & Shareholders' Equity	3,148	3,128	3,265	3,963	3,350
Total Common Shares Outstanding